Published in Invest Ophthalmol Vis Sci on December 13, 2008
Update on the oxidative stress theory of aging: does oxidative stress play a role in aging or healthy aging? Free Radic Biol Med (2009) 2.00
Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina. Proc Natl Acad Sci U S A (2013) 1.36
Oxidative stress and diabetes: what can we learn about insulin resistance from antioxidant mutant mouse models? Free Radic Biol Med (2011) 1.35
Low-intensity far-red light inhibits early lesions that contribute to diabetic retinopathy: in vivo and in vitro. Invest Ophthalmol Vis Sci (2013) 1.07
Same-session functional assessment of rat retina and brain with manganese-enhanced MRI. Neuroimage (2011) 1.07
Validation of structural and functional lesions of diabetic retinopathy in mice. Mol Vis (2010) 1.00
Loss of caveolin-1 impairs retinal function due to disturbance of subretinal microenvironment. J Biol Chem (2012) 0.93
Leukocytes from diabetic patients kill retinal endothelial cells: effects of berberine. Mol Vis (2013) 0.92
Oxidative stress and light-evoked responses of the posterior segment in a mouse model of diabetic retinopathy. Invest Ophthalmol Vis Sci (2015) 0.91
Adrenergic and serotonin receptors affect retinal superoxide generation in diabetic mice: relationship to capillary degeneration and permeability. FASEB J (2015) 0.90
Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase. Invest Ophthalmol Vis Sci (2014) 0.89
Manganese-enhanced magnetic resonance imaging (MEMRI). Methods Mol Biol (2011) 0.89
Delivery of antioxidant enzyme genes to protect against ischemia/reperfusion-induced injury to retinal microvasculature. Invest Ophthalmol Vis Sci (2009) 0.88
Acute systemic 11-cis-retinal intervention improves abnormal outer retinal ion channel closure in diabetic mice. Mol Vis (2012) 0.87
Photoreceptors in diabetic retinopathy. J Diabetes Investig (2015) 0.87
Catalase therapy corrects oxidative stress-induced pathophysiology in incipient diabetic retinopathy. Invest Ophthalmol Vis Sci (2015) 0.86
Evidence for diffuse central retinal edema in vivo in diabetic male Sprague Dawley rats. PLoS One (2012) 0.86
MRI biomarkers for evaluation of treatment efficacy in preclinical diabetic retinopathy. Expert Opin Med Diagn (2013) 0.85
Intraretinal calcium channels and retinal morbidity in experimental retinopathy of prematurity. Mol Vis (2011) 0.84
Human tumor cell proliferation evaluated using manganese-enhanced MRI. PLoS One (2012) 0.84
Retinylamine Benefits Early Diabetic Retinopathy in Mice. J Biol Chem (2015) 0.83
Exploration of molecular factors impairing superoxide dismutase isoforms activity in human senile cataractous lenses. Invest Ophthalmol Vis Sci (2013) 0.81
MRI of Retinal Free Radical Production With Laminar Resolution In Vivo. Invest Ophthalmol Vis Sci (2016) 0.79
Diabetic Retinopathy: Retina-Specific Methods for Maintenance of Diabetic Rodents and Evaluation of Vascular Histopathology and Molecular Abnormalities. Curr Protoc Mouse Biol (2015) 0.78
Development of an MRI biomarker sensitive to tetrameric visual arrestin 1 and its reduction via light-evoked translocation in vivo. FASEB J (2014) 0.78
Manganese-Enhanced MRI for Preclinical Evaluation of Retinal Degeneration Treatments. Invest Ophthalmol Vis Sci (2015) 0.77
Melanopsin Phototransduction Contributes to Light-Evoked Choroidal Expansion and Rod L-Type Calcium Channel Function In Vivo. Invest Ophthalmol Vis Sci (2016) 0.77
Metanx and early stages of diabetic retinopathy. Invest Ophthalmol Vis Sci (2015) 0.77
Layer-Specific Manganese-Enhanced MRI of the Diabetic Rat Retina in Light and Dark Adaptation at 11.7 Tesla. Invest Ophthalmol Vis Sci (2015) 0.77
Manganese-Enhanced MRI: Biological Applications in Neuroscience. Front Neurol (2015) 0.76
Measuring In Vivo Free Radical Production by the Outer Retina. Invest Ophthalmol Vis Sci (2015) 0.76
Systemic Retinaldehyde Treatment Corrects Retinal Oxidative Stress, Rod Dysfunction, and Impaired Visual Performance in Diabetic Mice. Invest Ophthalmol Vis Sci (2015) 0.76
In Vivo Evaluation of the Visual Pathway in Streptozotocin-Induced Diabetes by Diffusion Tensor MRI and Contrast Enhanced MRI. PLoS One (2016) 0.76
Photobiomodulation Mitigates Diabetes-Induced Retinopathy by Direct and Indirect Mechanisms: Evidence from Intervention Studies in Pigmented Mice. PLoS One (2015) 0.76
Imaging rhodopsin degeneration in vivo in a new model of ocular ischemia in living mice. FASEB J (2015) 0.75
High-fat and obesogenic diets: current and future strategies to fight obesity and diabetes. Genes Nutr (2014) 0.75
Genetically heterogeneous mice show age-related vision deficits not related to increased rod cell L-type calcium channel function in vivo. Neurobiol Aging (2016) 0.75
Sodium Iodate Produces a Strain-Dependent Retinal Oxidative Stress Response Measured In Vivo Using QUEST MRI. Invest Ophthalmol Vis Sci (2017) 0.75
Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest (1998) 4.92
Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria. J Biol Chem (2001) 3.78
A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry (2003) 3.42
Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res (2004) 3.08
Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn Reson Med (1997) 2.93
The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci (2005) 2.83
A schematic eye for the mouse, and comparisons with the rat. Vision Res (1985) 2.75
Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed (2004) 2.74
Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J (1984) 2.74
Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic Biol Med (2006) 2.62
Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci (2004) 2.62
Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci (2007) 2.28
Structural and functional MRI reveals multiple retinal layers. Proc Natl Acad Sci U S A (2006) 2.15
In vivo auditory brain mapping in mice with Mn-enhanced MRI. Nat Neurosci (2005) 2.14
Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci U S A (1987) 2.12
Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes (2004) 2.02
Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI. Invest Ophthalmol Vis Sci (2006) 1.84
Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes (2001) 1.79
Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci (2006) 1.60
Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology (1984) 1.55
Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care (1991) 1.53
RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Invest Ophthalmol Vis Sci (2000) 1.46
Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci (1998) 1.37
Cocaine-induced brain activation detected by dynamic manganese-enhanced magnetic resonance imaging (MEMRI). Proc Natl Acad Sci U S A (2007) 1.36
Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. Diabetes (2004) 1.36
Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp Diabetes Res (2007) 1.34
Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy. Invest Ophthalmol Vis Sci (2004) 1.30
Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radic Biol Med (1997) 1.29
Superoxide dismutase 1 protects retinal cells from oxidative damage. J Cell Physiol (2006) 1.27
Overexpression of Cu2+/Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes (2001) 1.26
Manganese-enhanced MRI studies of alterations of intraretinal ion demand in models of ocular injury. Invest Ophthalmol Vis Sci (2007) 1.25
Applications of manganese-enhanced magnetic resonance imaging (MEMRI) to imaging of the heart. NMR Biomed (2004) 1.21
A mouse model of diabetic retinopathy. Arch Ophthalmol (1996) 1.18
Retinal vascular autoregulation in diabetes mellitus. Ophthalmology (1982) 1.18
Paired-flash identification of rod and cone dysfunction in the diabetic rat. Invest Ophthalmol Vis Sci (2004) 1.15
High-resolution manganese-enhanced MRI of experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci (2007) 1.14
Localized detection of glioma glycolysis using edited 1H MRS. Magn Reson Med (1993) 1.10
Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic Acid. Invest Ophthalmol Vis Sci (2007) 1.09
Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes (1996) 1.07
Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione. Invest Ophthalmol Vis Sci (1994) 1.06
Ionic dysregulatory phenotyping of pathologic retinal thinning with manganese-enhanced MRI. Invest Ophthalmol Vis Sci (2008) 0.98
Adult and newborn rat inner retinal oxygenation during carbogen and 100% oxygen breathing. Comparison using magnetic resonance imaging delta Po2 mapping. Invest Ophthalmol Vis Sci (1996) 0.98
Altered retinal metabolism in diabetes. II. Measurement of sodium-potassium ATPase and total sodium and potassium in individual retinal layers. J Biol Chem (1986) 0.98
Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat. Curr Eye Res (2002) 0.98
Altered tissue content and cytosol distribution of trace metals in experimental diabetes. J Nutr (1981) 0.95
Manganese chloride stimulates rat microglia to release hydrogen peroxide. Toxicol Lett (2007) 0.95
Biometric measurement of the mouse eye using optical coherence tomography with focal plane advancement. Vision Res (2008) 0.94
Effect of vitamin C and lipoic acid on streptozotocin-induced diabetes gene expression: mRNA and protein expressions of Cu-Zn SOD and catalase. Mol Cell Biochem (2007) 0.93
Retinal oxygenation response and retinopathy. Prog Retin Eye Res (2005) 0.92
Manganese-enhanced MRI of human choroidal melanoma xenografts. Invest Ophthalmol Vis Sci (2007) 0.92
Chronic taurine supplementation ameliorates oxidative stress and Na+ K+ ATPase impairment in the retina of diabetic rats. Amino Acids (2002) 0.92
Intraretinal pH in diabetic cats. Curr Eye Res (2005) 0.88
An elevated level of copper zinc superoxide dismutase fails to prevent oxygen induced retinopathy in mice. Br J Ophthalmol (1996) 0.85
Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy. Curr Eye Res (2007) 0.85
Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci (1996) 0.84
Alterations in retinal Na+, K(+)-ATPase in diabetes: streptozotocin-induced and Zucker diabetic fatty rats. Curr Eye Res (1993) 0.84
Aberrant utilization of nitric oxide and regulation of soluble guanylate cyclase in rat diabetic retinopathy. Antioxid Redox Signal (2003) 0.79
Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity. Invest Ophthalmol Vis Sci (1996) 0.78
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J (2004) 5.33
Inflammation in diabetic retinopathy. Prog Retin Eye Res (2011) 3.29
The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J (2006) 3.15
Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT). Am Heart J (2002) 3.05
The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci (2005) 2.83
Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med (2009) 2.31
Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci (2007) 2.28
Are cancer-related decision aids effective? A systematic review and meta-analysis. J Clin Oncol (2009) 2.24
Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J (2002) 2.09
Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes (2002) 2.05
Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes (2004) 2.02
Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes (2007) 2.01
A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J Am Coll Cardiol (2011) 1.98
Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest Ophthalmol Vis Sci (2007) 1.90
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. Circulation (2006) 1.86
Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci (2005) 1.84
Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI. Invest Ophthalmol Vis Sci (2006) 1.84
Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure. J Am Coll Cardiol (2012) 1.65
Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes (2007) 1.61
How many patients? How many limbs? Analysis of patients or limbs in the orthopaedic literature: a systematic review. J Bone Joint Surg Am (2006) 1.57
Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo. Blood (2011) 1.51
5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy. Diabetes (2008) 1.48
Compound 49b prevents diabetes-induced apoptosis through increased IGFBP-3 levels. Invest Ophthalmol Vis Sci (2012) 1.46
A comprehensive analysis of the expression of crystallins in mouse retina. Mol Vis (2003) 1.43
Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol (2005) 1.43
Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT). J Thorac Cardiovasc Surg (2003) 1.39
Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech (2012) 1.38
Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina. Proc Natl Acad Sci U S A (2013) 1.36
Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function. Invest Ophthalmol Vis Sci (2010) 1.31
Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Diabetes (2006) 1.31
Application of isoproterenol inhibits diabetic-like changes in the rat retina. Exp Eye Res (2010) 1.27
Manganese-enhanced MRI of the DBA/2J mouse model of hereditary glaucoma. Invest Ophthalmol Vis Sci (2008) 1.27
Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front Biosci (Landmark Ed) (2009) 1.26
Manganese-enhanced MRI studies of alterations of intraretinal ion demand in models of ocular injury. Invest Ophthalmol Vis Sci (2007) 1.25
Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes (2002) 1.22
Marrow-derived cells regulate the development of early diabetic retinopathy and tactile allodynia in mice. Diabetes (2012) 1.21
Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Müller cells: model of diabetic retinopathy. J Biol Chem (2007) 1.19
High-resolution manganese-enhanced MRI of experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci (2007) 1.14
IGFBP-3 and TNF-α regulate retinal endothelial cell apoptosis. Invest Ophthalmol Vis Sci (2013) 1.14
Increased basement membrane thickness, pericyte ghosts, and loss of retinal thickness and cells in dopamine beta hydroxylase knockout mice. Exp Eye Res (2009) 1.12
Factors influencing outcome and treatment effect in PROACT II. Stroke (2003) 1.10
Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic Acid. Invest Ophthalmol Vis Sci (2007) 1.09
Increased tumor necrosis factor-α, cleaved caspase 3 levels and insulin receptor substrate-1 phosphorylation in the β₁-adrenergic receptor knockout mouse. Mol Vis (2011) 1.09
Quantitative mapping of ion channel regulation by visual cycle activity in rodent photoreceptors in vivo. Invest Ophthalmol Vis Sci (2008) 1.08
Low-intensity far-red light inhibits early lesions that contribute to diabetic retinopathy: in vivo and in vitro. Invest Ophthalmol Vis Sci (2013) 1.07
Implementation of a rapid response team decreases cardiac arrest outside of the intensive care unit. J Trauma (2007) 1.07
NRF2 plays a protective role in diabetic retinopathy in mice. Diabetologia (2013) 1.06
6-Fluoro-6-deoxy-D-glucose as a tracer of glucose transport. Am J Physiol Endocrinol Metab (2007) 1.06
CD40 mediates retinal inflammation and neurovascular degeneration. J Immunol (2008) 1.06
Oxidation of fatty acids is the source of increased mitochondrial reactive oxygen species production in kidney cortical tubules in early diabetes. Diabetes (2012) 1.05
Evidence of key tinnitus-related brain regions documented by a unique combination of manganese-enhanced MRI and acoustic startle reflex testing. PLoS One (2010) 1.04
Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c. Am J Physiol Endocrinol Metab (2008) 1.04
Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia. Mol Vis (2011) 1.04
Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats. Invest Ophthalmol Vis Sci (2004) 1.02
Effect of time to reperfusion on clinical outcome of anterior circulation strokes treated with thrombectomy: pooled analysis of the MERCI and Multi MERCI trials. Stroke (2011) 1.01
Role of hypoxia during normal retinal vessel development and in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci (2003) 1.01
β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype. PLoS One (2013) 1.01
Retracted Targets of tyrosine nitration in diabetic rat retina. Mol Cell Proteomics (2007) 1.00
Glutaredoxin regulates autocrine and paracrine proinflammatory responses in retinal glial (muller) cells. J Biol Chem (2008) 1.00
Retinal thickness and subnormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci (2006) 1.00
Curcumin inhibits neuronal and vascular degeneration in retina after ischemia and reperfusion injury. PLoS One (2011) 0.98
Leukocytes regulate retinal capillary degeneration in the diabetic mouse via generation of leukotrienes. J Leukoc Biol (2012) 0.98
Ionic dysregulatory phenotyping of pathologic retinal thinning with manganese-enhanced MRI. Invest Ophthalmol Vis Sci (2008) 0.98
Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC). J Biol Chem (2012) 0.97
Identification of primary retinal cells and ex vivo detection of proinflammatory molecules using flow cytometry. Mol Vis (2009) 0.97
Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke (2009) 0.96
Non-enzymatic glycation in corneas from normal and diabetic donors and its effects on epithelial cell attachment in vitro. Optometry (2003) 0.96
Regulation of the early subnormal retinal oxygenation response in experimental diabetes by inducible nitric oxide synthase. Diabetes (2004) 0.95
MyD88-dependent pathways in leukocytes affect the retina in diabetes. PLoS One (2013) 0.94
Evaluating "old" definitions for the "new" bronchopulmonary dysplasia. J Pediatr (2002) 0.94
Captopril inhibits glucose accumulation in retinal cells in diabetes. Invest Ophthalmol Vis Sci (2003) 0.94
Loss of caveolin-1 impairs retinal function due to disturbance of subretinal microenvironment. J Biol Chem (2012) 0.93
Toward clinical application of manganese-enhanced MRI of retinal function. Brain Res Bull (2009) 0.93
Relationship between attrition and neurodevelopmental impairment rates in extremely preterm infants at 18 to 24 months: a systematic review. Arch Pediatr Adolesc Med (2012) 0.92
Sulfasalazine blocks the development of tactile allodynia in diabetic rats. Diabetes (2008) 0.92
Manganese-enhanced MRI of human choroidal melanoma xenografts. Invest Ophthalmol Vis Sci (2007) 0.92
Leukocytes from diabetic patients kill retinal endothelial cells: effects of berberine. Mol Vis (2013) 0.92
African-Caribbean cancer consortium for the study of viral, genetic and environmental cancer risk factors. Infect Agent Cancer (2007) 0.92
Retinal channelrhodopsin-2-mediated activity in vivo evaluated with manganese-enhanced magnetic resonance imaging. Mol Vis (2010) 0.91
Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase. Invest Ophthalmol Vis Sci (2014) 0.89
Deletion of aldose reductase from mice inhibits diabetes-induced retinal capillary degeneration and superoxide generation. PLoS One (2013) 0.89